価格表

在庫・価格 : 2025年10月17日 20時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Calreticulin, Rabbit-Poly, Atto 488
データシート
SPC-122B-A488 STQストレスマークバイオサイエンス
StressMarq Biosciences Inc.
200 μl ¥92,000
(未発注)
追加

在庫・価格 : 2025年10月17日 20時43分 現在

Anti-Calreticulin, Rabbit-Poly, Atto 488

  • 商品コード:SPC-122B-A488
  • メーカー:STQ
  • 包装:200μl
  • 価格: ¥92,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Pujol FM et al. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites. J. Virol. 2016 Aug;90(15):6709-23
Pujol FM et al
2016/01/01
PubMed
2 Kluge SF et al. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe 2014 Nov;16(5):639-50
Kluge SF et al
2014/01/01
PubMed
3 Frenz T et al. Independent of plasmacytoid dendritic cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of different composition as opposed to pDC stimulated with free virus. J. Immunol. 2014 Sep;193(5):2496-50
Frenz T et al
2014/01/01
PubMed
4 Koide N et al. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB. Immunol. Lett. 2014 May;161(1):31-37
Koide N et al
2014/01/01
PubMed
5 Kobayashi M et al. Ascorbic acid deficiency decreases hepatic cytochrome P-450, especially CYP2B1/2B2, and simultaneously induces heme oxygenase-1 gene expression in scurvy-prone ODS rats. Biosci. Biotechnol. Biochem. 2014;78(6):1060-6
Kobayashi M et al
2014/01/01
PubMed
6 Tongu M et al. Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma. Cancer Immunol. Immunother. 2010 May;59(5):769-77
Tongu M et al
2010/01/01
PubMed
7 Ursic K et al. Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma. Bioelectrochemistry 2018 Feb;119:161-171
Ursic K et al
2018/01/01
PubMed
8 Harada K et al. Calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma. Oncol Lett 2017 Jun;13(6):4857-4862
Harada K et al
2017/01/01
PubMed
9 Zhang Z et al. Rational design of ICD-inducing nanoparticles for cancer immunotherapy. Sci Adv 2024 Feb;10(6):eadk0716
Zhang Z et al
2024/01/01
PubMed
10 Zhao HY et al. A mitochondria-targeting dihydroartemisinin derivative as a reactive oxygen species -based immunogenic cell death inducer. iScience 2024 Jan;27(1):108702
Zhao HY et al
2024/01/01
PubMed
11 Liu Y et al. Targeting the Negative Feedback of Adenosine-A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy. Adv Sci (Weinh) 2022 May;9(14):e2104182
Liu Y et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Pujol FM et al. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites. J. Virol. 2016 Aug;90(15):6709-23
    Pujol FM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kluge SF et al. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe 2014 Nov;16(5):639-50
    Kluge SF et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Frenz T et al. Independent of plasmacytoid dendritic cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of different composition as opposed to pDC stimulated with free virus. J. Immunol. 2014 Sep;193(5):2496-50
    Frenz T et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Koide N et al. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB. Immunol. Lett. 2014 May;161(1):31-37
    Koide N et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kobayashi M et al. Ascorbic acid deficiency decreases hepatic cytochrome P-450, especially CYP2B1/2B2, and simultaneously induces heme oxygenase-1 gene expression in scurvy-prone ODS rats. Biosci. Biotechnol. Biochem. 2014;78(6):1060-6
    Kobayashi M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Tongu M et al. Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma. Cancer Immunol. Immunother. 2010 May;59(5):769-77
    Tongu M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ursic K et al. Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma. Bioelectrochemistry 2018 Feb;119:161-171
    Ursic K et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Harada K et al. Calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma. Oncol Lett 2017 Jun;13(6):4857-4862
    Harada K et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Zhang Z et al. Rational design of ICD-inducing nanoparticles for cancer immunotherapy. Sci Adv 2024 Feb;10(6):eadk0716
    Zhang Z et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Zhao HY et al. A mitochondria-targeting dihydroartemisinin derivative as a reactive oxygen species -based immunogenic cell death inducer. iScience 2024 Jan;27(1):108702
    Zhao HY et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Liu Y et al. Targeting the Negative Feedback of Adenosine-A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy. Adv Sci (Weinh) 2022 May;9(14):e2104182
    Liu Y et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed